Poster Exhibition 1

[PE-130] EFFICACY AND SAFETY OF GUSELKUMAB FOR ULCERATIVE COLITIS THROUGH WEEK 92 OF THE QUASAR LONG-TERM EXTENSION STUDY

*TADAKAZU HISAMATSU¹, Mary R. Lichtenstein², Jessica R. Allegretti³, David T Rubin⁴, Brian G. Feagan⁵, Brian Bressler⁶, Julián Panés⁷, Waqqas Afif⁸, Mark A Samaan⁹, Byong Duk Ye¹⁰, Shadi Yarandi¹¹, Matthew Germinaro¹¹, Nicole Shipitofsky¹¹, Ye Miao¹¹, Pankaj Mistry¹¹, Hongyan Zhang¹¹, Axel Dignass¹², Bruce E. Sands¹³, Laurent Peyrin- Biroulet¹⁴ (1. Kyorin University School of Medicine, Tokyo, Japan, 2. University of Pennsylvania, Philadelphia, PA, USA, 3. Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, 4. University of Chicago Medicine Inflammatory Bowel Disease Centre, Chicago, IL, USA, 5. Western University, London, ON, Canada, 6. University of British Columbia, Vancouver, BC, Canada, 7. Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain, 8. Division of Gastroenterology, McGill University Health Care, Montréal, Québec, CA, 9. Inflammatory Bowel Disease Unit, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, 10. University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 11. Janssen Research & Development, LLC, Spring House, PA, USA, 12. Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany, 13. Icahn School of Medicine at Mount Sinai, New York, NY, USA, 14. University of Lorraine, Inserm, NGERE, F-54000 Nancy, France and Groupe Hospitalier Privé Ambroise Paré-Hartmann, Paris IBD Centre, 92200 Neuilly-sur-Seine, France)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.